Boon Peng Lim

988 total citations
24 papers, 586 citations indexed

About

Boon Peng Lim is a scholar working on Surgery, Economics and Econometrics and Psychiatry and Mental health. According to data from OpenAlex, Boon Peng Lim has authored 24 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Economics and Econometrics and 5 papers in Psychiatry and Mental health. Recurrent topics in Boon Peng Lim's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmaceutical Economics and Policy (4 papers) and Coronary Interventions and Diagnostics (3 papers). Boon Peng Lim is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Pharmaceutical Economics and Policy (4 papers) and Coronary Interventions and Diagnostics (3 papers). Boon Peng Lim collaborates with scholars based in Singapore, United States and China. Boon Peng Lim's co-authors include Ai Leng Khoo, Monica Teng, Ying Zhao, Jason Cheah, Pradeep Paul George, Liang Lin, Liang‐Ting Lin, Tiong Cheng Yeo, Hui Zhou and Yee Ming Mok and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Nutrition Reviews and International Journal of Antimicrobial Agents.

In The Last Decade

Boon Peng Lim

24 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Boon Peng Lim Singapore	12	122	115	99	80	80	24	586
James A. G. Crispo Canada	15	51 0.4×	89 0.8×	70 0.7×	108 1.4×	84 1.1×	57	857
Harmeet Singh Rehan India	18	113 0.9×	78 0.7×	50 0.5×	59 0.7×	107 1.3×	64	964
P.H.M. van der Kuy Netherlands	17	127 1.0×	109 0.9×	124 1.3×	72 0.9×	192 2.4×	70	961
Mohd Makmor‐Bakry Malaysia	14	120 1.0×	85 0.7×	32 0.3×	88 1.1×	111 1.4×	111	763
Nailya Bulatova Jordan	18	286 2.3×	55 0.5×	106 1.1×	110 1.4×	46 0.6×	61	816
Dana G. Carroll United States	12	156 1.3×	60 0.5×	63 0.6×	36 0.5×	39 0.5×	38	597
Olivia Leoni Italy	16	83 0.7×	60 0.5×	57 0.6×	93 1.2×	56 0.7×	82	753
Jens Bos Netherlands	18	101 0.8×	92 0.8×	107 1.1×	73 0.9×	156 1.9×	74	834
Marta Castro Spain	13	166 1.4×	53 0.5×	112 1.1×	180 2.3×	43 0.5×	25	842
Sieta T. de Vries Netherlands	13	121 1.0×	119 1.0×	42 0.4×	42 0.5×	35 0.4×	45	672

Countries citing papers authored by Boon Peng Lim

Since Specialization

Citations

This map shows the geographic impact of Boon Peng Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boon Peng Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boon Peng Lim more than expected).

Fields of papers citing papers by Boon Peng Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boon Peng Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boon Peng Lim. The network helps show where Boon Peng Lim may publish in the future.

Co-authorship network of co-authors of Boon Peng Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Boon Peng Lim. A scholar is included among the top collaborators of Boon Peng Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boon Peng Lim. Boon Peng Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khoo, Ai Leng, Ying Zhao, Monica Teng, et al.. (2018). Evaluation of a risk-guided strategy for empirical carbapenem use in febrile neutropenia. International Journal of Antimicrobial Agents. 52(3). 350–357. 6 indexed citations

Lim, Boon Peng, et al.. (2018). Health Technology Disinvestment in Singapore. Annals of the Academy of Medicine Singapore. 47(8). 338–344. 5 indexed citations

Teng, Monica, Ying Zhao, Ai Leng Khoo, et al.. (2018). Cost‐effectiveness analysis of biodegradable polymer versus durable polymer drug‐eluting stents incorporating real‐world evidence. Cardiovascular Therapeutics. 36(5). e12442–e12442. 3 indexed citations

Zhao, Ying, Monica Teng, Ai Leng Khoo, et al.. (2018). A propensity score‐matched comparison of biodegradable polymer vs second‐generation durable polymer drug‐eluting stents in a real‐world population. Cardiovascular Therapeutics. 36(2). 1 indexed citations

Zhao, Ying, et al.. (2017). Cost-Effectiveness Modeling of Repetitive Transcranial Magnetic Stimulation Compared to Electroconvulsive Therapy for Treatment-Resistant Depression in Singapore. Neuromodulation Technology at the Neural Interface. 21(4). 376–382. 20 indexed citations

Zhao, Ying, Liang Lin, Monica Teng, et al.. (2016). Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials. BJPsych Open. 2(1). 59–66. 35 indexed citations

Khoo, Ai Leng, et al.. (2016). INTEGRATING HEALTH TECHNOLOGY ASSESSMENT PRINCIPLES IN FORMULARY MANAGEMENT. International Journal of Technology Assessment in Health Care. 32(1-2). 81–87. 5 indexed citations

Zhao, Ying, Ai Leng Khoo, Monica Teng, et al.. (2016). Cost‐effectiveness of strategy‐based approach to treatment of genotype 1 chronic hepatitis C. Journal of Gastroenterology and Hepatology. 31(9). 1628–1637. 9 indexed citations

Zhao, Ying, et al.. (2016). Cost-effectiveness modelling of novel oral anticoagulants incorporating real-world elderly patients with atrial fibrillation. International Journal of Cardiology. 220. 794–801. 20 indexed citations

10.

Khoo, Ai Leng, Hui Zhou, Monica Teng, et al.. (2015). Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants. CNS Drugs. 29(8). 695–712. 49 indexed citations

11.

Zhao, Ying, Ai Leng Khoo, Liang‐Ting Lin, et al.. (2015). Cost-Effectiveness Analysis of Ticagrelor and Prasugrel for the Treatment of Acute Coronary Syndrome. Value in Health Regional Issues. 9. 22–27. 9 indexed citations

12.

Lin, Liang, Ying Zhao, Hui Zhou, et al.. (2015). Comparative cost-effectiveness of 11 oral antipsychotics for relapse prevention in schizophrenia within Singapore using effectiveness estimates from a network meta-analysis. International Clinical Psychopharmacology. 31(2). 84–92. 18 indexed citations

13.

Lin, Liang, Wee Shiong Lim, Hui Zhou, et al.. (2015). Clinical and Safety Outcomes of Oral Antithrombotics for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Network Meta-analysis. Journal of the American Medical Directors Association. 16(12). 1103.e1–1103.e19. 44 indexed citations

14.

Teng, Monica, Liang‐Ting Lin, Ying Zhao, et al.. (2015). Statins for Primary Prevention of Cardiovascular Disease in Elderly Patients: Systematic Review and Meta-Analysis. Drugs & Aging. 32(8). 649–661. 59 indexed citations

15.

Lin, Liang‐Ting, Monica Teng, Ying Zhao, et al.. (2015). Long-term Cost-effectiveness of Statin Treatment for Primary Prevention of Cardiovascular Disease in the Elderly. Cardiovascular Drugs and Therapy. 29(2). 187–197. 17 indexed citations

16.

Zhao, Yue, et al.. (2015). Meta-analysis of the effectiveness of esomeprazole in gastroesophageal reflux disease and Helicobacter pylori infection. Journal of Clinical Pharmacy and Therapeutics. 40(4). 368–375. 6 indexed citations

17.

Zhao, Ying, Ai Leng Khoo, Monica Teng, et al.. (2015). Network Meta-analysis and Pharmacoeconomic Evaluation of Fluconazole, Itraconazole, Posaconazole, and Voriconazole in Invasive Fungal Infection Prophylaxis. Antimicrobial Agents and Chemotherapy. 60(1). 376–386. 42 indexed citations

18.

Lin, Liang, Ying Zhao, Paul Chew, et al.. (2014). Comparative Efficacy and Tolerability of Topical Prostaglandin Analogues for Primary Open-Angle Glaucoma and Ocular Hypertension. Annals of Pharmacotherapy. 48(12). 1585–1593. 41 indexed citations

19.

Khoo, Ai Leng, et al.. (2013). A Multicenter, Multidisciplinary, High-Alert Medication Collaborative to Improve Patient Safety: The Singapore Experience. The Joint Commission Journal on Quality and Patient Safety. 39(5). 205–212. 9 indexed citations

20.

George, Pradeep Paul, et al.. (2010). The Evolving Role of the Community Pharmacist in Chronic Disease Management - A Literature Review. Annals of the Academy of Medicine Singapore. 39(11). 861–867. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact